StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SPX.AX$0.02+0.00%
Fair $0.02+0.0%

SPX.AX

Spenda Limited

Technology / Software - InfrastructureASX

$0.02

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $0.02Fund rank 28/100 · Data gapFallback financials|
SA 16/F
F-Score: 3/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 22%

FCF escenarios

weak_data · normalized FCF $-7.9M · quality 63.7/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 32/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

16/100

F

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -38.3%, below the 5% threshold
Thesis & Journal · SPX.AXLocal privado en este navegador · Spenda Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$5M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-38.3%

↓

Gross Margin

56.3%

↑

Debt/Equity

0.40

↑
52-Week Range$0
$0$0

TradingView lightweight chart

SPX.AX price, volumen y niveles de valoración

Último $0.017Periodo -99.9%
Fair value: $0.017

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2021–2024 · 3 años de histórico normalizado

Revenue CAGR

+84.0%

FCF CAGR

—

FCF margin

-154.0%

FCF / Net income

0.60x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $5.1M · net income $-13.2M · FCF $-7.9M

2021-FY → 2024-FY

Gross margin

56.3%+3.5% pts

Operating margin

-214.2%+670.3% pts

Net margin

-256.9%+1127.2% pts

FCF margin

-154.0%+216.7% pts
MetricTTM
2024
2023
2022
2021
Income Statement
Revenue$5.1M$5.1M$2.9M$2.0M$824567.00
Net Income$-13.2M$-13.2M$-11.0M$-50.2M$-11.4M
EBITDA$-8.7M$-8.7M$-6.9M$-51.3M$-11.2M
EPS-0.00-0.00-0.00-0.02-0.01
Gross Margin56.3%56.3%50.9%51.4%52.9%
Operating Margin-214.2%-214.2%-388.0%-770.0%-884.5%
Net Margin-256.9%-256.9%-380.7%-2498.0%-1384.1%
Balance Sheet
Debt/Equity0.400.400.320.190.00
Current Ratio0.700.70———
Cash Flow
Free Cash Flow$-7.9M$-7.9M$-5.7M$-10.6M$-3.1M
Returns
ROE-38.3%-38.3%-28.8%-115.8%-14.0%
Valuation
P/B1.951.9513.5718.5922.89
Growth & Yield
Revenue Growth77.9%77.9%43.7%143.9%—
EPS Growth2.9%2.9%79.0%-149.2%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -87.9%

Total return

-87.9%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.00 → -0.00

Residual

-87.9%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-87.9%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.